PET and PET/CT imaging center developer Imagin Molecular of Hinsdale, IL, has added to its investment in molecular imaging vendor Positron of Fishers, IN.
Imagin completed the acquisition of 3.1 million Positron Class B preferred shares, which have value in excess of $35 million. The Class B preferred shares are convertible, one for 100, into Positron common shares. Imagin said it intends to hold the shares for investment purposes.
Imagin has held preferred shares in Positron since 2005. Once this transaction is complete, it will own the equivalent of 3.9 million Positron common shares, Imagin said.
Related Reading
Positron gets La. contract, March 4, 2010
NRC licenses Positron facility, March 2, 2010
Positron adds install, December 16, 2009
Imagin to use Cadenza software, June 20, 2006
Imagin nets regulatory approval, June 19, 2006
Copyright © 2010 AuntMinnie.com
